Gujarat Themis Biosyn Limited — Board Meeting, 20-05-2025: Outcome of Board Meeting

Gujarat Themis Biosyn has announced a board meeting that approved the audited financial results for the quarter and year ended March 31, 2025. The company reported a net profit of ₹15.88 Cr for the year with EPS at ₹4.48. A final dividend of Re. 0.67 per share is proposed, subject to shareholder approval. The board appointed M/s. KRS AND Co. as Secretarial Auditors for five years from FY26 and re-appointed M/s. Raja Dutta & Co. as Cost Auditors for FY26. The company is focusing on compliance and cost controls amid stable operations.